NOAEL Studies
Cosmetic Ingredient
HC Orange No. 6 NOAEL Studies
INCI: HC ORANGE NO. 6
CAS: 1449653-83-1
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
SCCS Opinion 8 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =300 | mg/kg bw/day | rat | - | Chronic | genotoxicity | p.18 |
| SCCS Opinion | NOAEL | =100 | mg/kg/day | - | - | developmental | developmental toxicity | p.25 |
| SCCS Opinion | NOAEL | =300 | mg/kg/day | - | - | developmental | developmental toxicity | p.25 |
| SCCS Opinion | NOAEL | =10 | mg/kg bw | rat | oral | prenatal | developmental toxicity | p.26 |
| SCCS Opinion | NOAEL | =100 | mg/kg bw/d | rat | oral | prenatal | developmental toxicity | p.26 |
| SCCS Opinion | NOAEL | =50 | mg/kg bw/d | rat | oral | prenatal | developmental toxicity | p.26 |
| SCCS Opinion | NOAEL | =19 | % | rat | oral | 90 days | repeated dose toxicity | p.27 |
| SCCS Opinion | NOAEL | =100 | mg/kg | - | dermal | developmental | developmental toxicity | p.27 |
Regulatory source 10 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | developmental toxicity | 100 | mg/kg/day | - | - | developmental | developmental toxicity | p.25 |
| Regulatory source | developmental toxicity | 100 | mg/kg | - | - | developmental | developmental toxicity | p.25 |
| Regulatory source | developmental toxicity | 300 | mg/kg/day | - | - | developmental | developmental toxicity | p.25 |
| Regulatory source | developmental toxicity | 10 | mg/kg bw | rat | oral | prenatal | developmental toxicity | p.26 |
| Regulatory source | developmental toxicity | =100 | mg/kg bw/d | rat | oral | prenatal | developmental toxicity | p.26 |
| Regulatory source | developmental toxicity | =50 | mg/kg bw/d | rat | oral | prenatal | developmental toxicity | p.26 |
| Regulatory source | developmental toxicity | 300 | mg/kg/day | rat | - | 90 days | developmental toxicity | p.27 |
| Regulatory source | developmental toxicity | 100 | mg/kg | - | dermal | developmental | developmental toxicity | p.27 |
| Regulatory source | genotoxicity | 300 | mg/kg bw/day | rat | - | Chronic | genotoxicity | p.18 |
| Regulatory source | repeated dose toxicity | 19 | % | rat | oral | 90 days | repeated dose toxicity | p.27 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | PKS7O14JK4 | UNII | - | - | - | chemical | - |